COVID-19

News

scientifically visualization of a coronavirus spike protein

Lilly begins trial of COVID-19 antibody treatment

Eli Lilly has started dosing patients in the world's first trial for a medicine specifically designed to attack SARS-CoV-2, the virus that causes COVID-19.

Views & Analysis

Teva’s Kim Innes on shaping the post-COVID future with the N...

Like all UK pharma GMs working during the COVID-19 pandemic, Teva’s Kim Innes has found herself leading her company through an unprecedented crisis in one of the worst-hit countries in the

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Accelerating pharma's digital IQ as customer engagement evol...

The COVID-19 pandemic has brought many changes to the pharmaceutical industry, among them how companies can continue to engage with healthcare professionals (HCPs) and other stakeholders.

Views & Analysis

COVID-19 is accelerating non-adherence and magnifying health inequalities

COVID-19 accelerates non-adherence and magnifies health ineq...

Non-adherence to medication has long been a thorn in the side of effective healthcare management – and the COVID-19 emergency is only serving to compound the problem.

Views & Analysis